EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark RETEVMO was filed as Word mark on 03/25/2019 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/24/2019.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018040622 |
| Application date | March 25, 2019 |
| Publication date | June 17, 2019 |
| Entry date | September 24, 2019 |
| Expiration date | March 25, 2029 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations namely, pharmaceutical preparations for the treatment, diagnosis and/or prevention of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy and ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain; pharmaceutical preparations
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| October 8, 2019 | Change Representative, Notified |
ID: 11018040622